Request Trial
shutterstock_1386380144_ingus_kruklitis
Ingus Kruklitis / Shutterstock.com
4 June 2019

C5’s 18th International forum on Pharmaceutical Patent Term Extensions

Don’t miss this opportunity to join the European Commission, European Patent Office, German, Netherland, and Portuguese patent offices, and leading pharmaceutical in-house decision makers to tackle current pharma patent term extensions challenges in Europe and worldwide at C5’s 18th International forum on Pharmaceutical Patent Term Extensions in Munich, June 25 & 26.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
10 July 2026   Harbour’s trial counsel shares the strategy behind the company’s $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science.
Americas
Exelixis opens two-front patent dispute over Cabometyx copies
9 July 2026   Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.
Europe
UPC upholds injunction in Invisalign maker’s software dispute with rival
9 July 2026   China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer orthodontic planning software in Europe with certain functionality.


Editor's picks

What’s at stake in Australia’s biggest pharma patent appeal in years?
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026

Editor's picks

Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026
Biotech
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026
Pharma
US life sciences damages averaged $33.5m between 2019-2025
18 June 2026
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

More features

UPC upholds injunction in Invisalign maker’s software dispute with rival
What’s at stake in Australia’s biggest pharma patent appeal in years?
US life sciences damages averaged $33.5m between 2019-2025
WATCH: Life after ADI 5529—how Brazil is redesigning its patent system since 2021, from patent term extensions to patent certainty
WATCH: China patent landscape
WATCH: Navigating the regulatory-IP nexus—maximizing exclusivity in an evolving policy landscape
EU court under pressure to define SPC limits in patent row
Baker McKenzie strengthens IP bench with new German lead